These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8415309)

  • 41. [Thalidomide in the treatment of aphthosis and Behçet's disease. 4 years' experience].
    Torras H; Lecha M; Mascaró/ JM
    Med Cutan Ibero Lat Am; 1982; 10(2):103-112. PubMed ID: 6759802
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of resistant aphthous ulceration with thalidomide in patients positive for HIV antibody.
    Youle M; Clarbour J; Farthing C; Connolly M; Hawkins D; Staughton R; Gazzard B
    BMJ; 1989 Feb; 298(6671):432. PubMed ID: 2495052
    [No Abstract]   [Full Text] [Related]  

  • 43. Thalidomide for mouth ulcers and wasting.
    Baker R
    BETA; 1995 Dec; ():8. PubMed ID: 11363016
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thalidomide heals HIV-related oral ulcers, but caution is required.
    Am J Health Syst Pharm; 1997 Jul; 54(13):1485-6. PubMed ID: 9217937
    [No Abstract]   [Full Text] [Related]  

  • 45. Thalidomide effective treatment for AIDS-related mouth ulcers.
    Randall P
    NIAID AIDS Agenda; 1995 Dec; ():2. PubMed ID: 11363350
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thalidomide-associated thrombosis in the treatment of HIV-associated severe aphthous disease: a case report and review of the literature.
    Hodowanec AC; Han A; Barker DE; Rubinstein PG; Max B
    J Int Assoc Physicians AIDS Care (Chic); 2012; 11(6):345-7. PubMed ID: 22930795
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of recurrent oral aphthous ulcers with etanercept.
    Scheinberg MA
    Clin Exp Rheumatol; 2002; 20(5):733-4. PubMed ID: 12412213
    [No Abstract]   [Full Text] [Related]  

  • 48. Thalidomide, orogenital ulcers, and risk of teratogenicity.
    Jenkins S; Powell RJ; Allen BR; Littlewood S; Maurice PD; Smith NJ
    Lancet; 1985 Mar; 1(8427):511. PubMed ID: 2857866
    [No Abstract]   [Full Text] [Related]  

  • 49. Thalidomide use in pediatric patients.
    Bessmertny O; Pham T
    Ann Pharmacother; 2002 Mar; 36(3):521-5. PubMed ID: 11895068
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Treatment of aphthae and aphthosis].
    Bull Acad Natl Chir Dent; 1984-1985; (30):119-26. PubMed ID: 6085929
    [No Abstract]   [Full Text] [Related]  

  • 51. Thalidomide in severe orogenital ulceration.
    Jenkins JS; Powell RJ; Allen BR; Littlewood SM; Maurice PD; Smith NJ
    Lancet; 1984 Dec; 2(8417-8418):1424-6. PubMed ID: 6151044
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Randomized controlled clinical trial on dose optimization of thalidomide in maintenance treatment for recurrent aphthous stomatitis.
    Deng Y; Wei W; Wang Y; Pan L; Du G; Yao H; Tang G
    J Oral Pathol Med; 2022 Jan; 51(1):106-112. PubMed ID: 34773292
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thalidomide effective in treating AIDS-related mouth ulcers.
    AIDS Patient Care STDS; 1996 Feb; 10(1):51. PubMed ID: 11361666
    [No Abstract]   [Full Text] [Related]  

  • 54. Ovarian failure with thalidomide treatment in complex aphthosis: comment on the concise communication by Ordi et al.
    Gompel A; Frances C; Piette JC; Blanc AS; Cordoliani F; Piette AM
    Arthritis Rheum; 1999 Oct; 42(10):2259-60. PubMed ID: 10524707
    [No Abstract]   [Full Text] [Related]  

  • 55. Thalidomide as treatment of refractory aphthous ulceration related to human immunodeficiency virus infection.
    Paterson DL; Georghiou PR; Allworth AM; Kemp RJ
    Clin Infect Dis; 1995 Feb; 20(2):250-4. PubMed ID: 7742424
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thalidomide for wasting syndrome: progress toward compromise.
    James JS
    AIDS Treat News; 1995 Nov; (no 234):1-5. PubMed ID: 11363041
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Treatment of recurrent aphthous stomatitis. A bibliographic review].
    Lacosta Nicolás JL; Martínez Iñiguez JC
    Rev Clin Esp; 1998 Apr; 198(4):234-6. PubMed ID: 9633209
    [No Abstract]   [Full Text] [Related]  

  • 58. Effect of thalidomide on orogenital ulceration.
    Bowers PW; Powell RJ
    Br Med J (Clin Res Ed); 1983 Sep; 287(6395):799-800. PubMed ID: 6412834
    [No Abstract]   [Full Text] [Related]  

  • 59. Thalidomide: an alternative therapy for treatment of apthous ulcers (canker sores).
    Manesis DA
    STEP Perspect; 1995; 7(1):16-7. PubMed ID: 11362397
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of rebamipide as adjunctive therapy in the treatment of recurrent oral aphthous ulcers in patients with Behçet's disease: a randomised, double-blind, placebo-controlled study.
    Matsuda T; Ohno S; Hirohata S; Miyanaga Y; Ujihara H; Inaba G; Nakamura S; Tanaka S; Kogure M; Mizushima Y
    Drugs R D; 2003; 4(1):19-28. PubMed ID: 12568631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.